Trading Signals: UTHR Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Fri. Dec. 22, 2023)( United Therapeutics Corp)
| UTHR latest price $113.1600 (-1.33%) ($112.9300 - $114.5900) on Tue. Jul. 28, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.81% (three month average) | RSI | 42 | Latest Price | $113.1600(-1.33%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | UTHR declines -1.6% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support UTHR advance at 0% a week (0% probability) XLV(35%) IBB(30%) VFMO(29%) VYM(29%) XBI(29%) | Factors Impacting UTHR price | UTHR will decline at least -0.905% in a week (0% probabilities). VIXM(-19%) VXX(-15%) UUP(-11%) XLC(-9%) TLT(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.905% (StdDev 1.81%) | Hourly BBV | 0 () | Intraday Trend | -1% | | | |
|
1 - 5 Day Possible Target | $110.81(-2.08%) | Resistance Level | $116.72 | 5 Day Moving Average | $113.62(-0.4%) | 10 Day Moving Average | $114.98(-1.58%) | 20 Day Moving Average | $116.72(-3.05%) | To recent high | -10.1% | To recent low | 4.8% | Market Cap | $5.019b | | | | United Therapeutics Corp. operates as a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening diseases. It markets and sells commercial therapies to treat pulmonary arterial hypertension and high-risk neuroblastoma. The firm also involves in the research and development of new indications and delivery devices for its product, and for the organ transplantation-related technologies. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD. |